INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Cedars-Sinai Medical Center
Los Ángeles, Estados UnidosPublicaciones en colaboración con investigadores/as de Cedars-Sinai Medical Center (6)
2024
-
Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study
JACC: Cardiovascular Interventions, Vol. 17, Núm. 3, pp. 374-387
2018
-
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study
The Lancet Oncology, Vol. 19, Núm. 3, pp. 370-381
-
Ibrutinib as treatment for patients with relapsed/refractory follicular lymphoma: Results from the open-label, multicenter, phase II DAWN study
Journal of Clinical Oncology, Vol. 36, Núm. 23, pp. 2405-2412
2011
2010
-
Monoclonal gammopathy of undetermined significance: A consensus statement: Guideline
British Journal of Haematology, Vol. 150, Núm. 1, pp. 28-38